Danaher Corporation (DHR) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.

Total Revenue Chart for Danaher Corporation

Danaher Corporation (DHR) revenue for FY2025 was USD 24.6B, a 2.9% change from FY2024. Danaher Corporation's revenue grew from USD 298.0M in 1985 to USD 24.6B in 2025 (8144.3% over 40 years). Earnings per share grew from USD 0.56 in 2000 to USD 5.08 in 2025 (812.4%). Revenue compound annual growth rate: 5-year CAGR of 2.0%, 10-year CAGR of 5.5%, 20-year CAGR of 5.8%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$140.58B
Implied Share Price
$199.98
Enterprise Value
$159.28B
Revenue (TTM)
$25.11B
EBITDA
$8.03B
Profit Margin
15.95%
Trailing P/E
35.65
Forward P/E
22.88
Price/Book (MRQ)
2.61
Price/Sales (TTM)
5.60
EV/EBITDA
21.00
EV/Revenue
6.34
Dividend Yield
0.72%
Book Value
$74.81
Free Cash Flow (FY2025)
$5.26B
Free Cash Flow Yield
3.74%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.